Get the Stockscreener App
2.59
11.90%
-0.35
After Hours:
2.65
0.06
+2.32%
Novabay Pharmaceuticals Inc stock is traded at $2.59, with a volume of 1.46M.
It is down -11.90% in the last 24 hours and up +342.89% over the past month.
NovaBay Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets non-antibiotic and anti-infective products for the eye care market in the United States, China, and internationally. It offers Avenova, a prescription product for cleansing and removing foreign materials, including microorganisms and debris from skin around the eye; NeutroPhase for wound care market; CelleRx for the aesthetic dermatology market; Aganocide compounds patented synthetic molecules for use against bacteria, viruses, and fungi; auriclosene irrigation solution for urology; and intelli-Case, a device for soft and rigid gas permeable contact lenses. NovaBay Pharmaceuticals, Inc. has collaboration and license agreement with Virbac to develop auriclosene, a proprietary compound for veterinary markets. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is based in Emeryville, California.
See More
Previous Close:
$2.94
Open:
$3
24h Volume:
1.46M
Relative Volume:
0.24
Market Cap:
$15.08M
Revenue:
$14.64M
Net Income/Loss:
$-13.74M
P/E Ratio:
-0.3563
EPS:
-7.27
Net Cash Flow:
$-5.04M
1W Performance:
-30.56%
1M Performance:
+342.89%
6M Performance:
+307.87%
1Y Performance:
+448.85%
1-Day Range:
$2.52
$3.06
1-Week Range:
$2.28
$3.46
52-Week Range:
$0.46
$4.44
Novabay Pharmaceuticals Inc Stock (NBY) Company Profile
Name
Novabay Pharmaceuticals Inc
Sector
Industry
Phone
510-899-8800
Address
2000 Powell Street, Suite 1150, Emeryville, CA
Compare NBY with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NBY
Novabay Pharmaceuticals Inc
|
2.59 | 14.03M | 14.64M | -13.74M | -5.04M | -7.27 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Novabay Pharmaceuticals Inc Stock (NBY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-18-19 | Initiated | Ladenburg Thalmann | Buy |
| Jul-06-18 | Reiterated | H.C. Wainwright | Buy |
| Nov-15-17 | Reiterated | Laidlaw | Buy |
| Jun-05-17 | Initiated | ROTH Capital | Buy |
| Mar-27-17 | Initiated | Laidlaw | Buy |
| Feb-06-17 | Initiated | Rodman & Renshaw | Buy |
| Mar-07-16 | Downgrade | Maxim Group | Buy → Hold |
| Dec-14-15 | Reiterated | Maxim Group | Buy |
| Apr-30-15 | Resumed | Maxim Group | Buy |
| Mar-06-13 | Initiated | Ascendiant Capital Markets | Strong Buy |
| Jan-03-08 | Initiated | Dawson James | Speculative Buy |
View All
Novabay Pharmaceuticals Inc Stock (NBY) Latest News
What technical models suggest about NovaBay Pharmaceuticals Inc.’s comeback2025 Technical Overview & Weekly High Return Stock Forecasts - Newser
Live market analysis of NovaBay Pharmaceuticals Inc.Portfolio Gains Summary & Accurate Trade Setup Notifications - Newser
Will NovaBay Pharmaceuticals Inc. outperform the marketJuly 2025 Spike Watch & Daily Oversold Bounce Ideas - Newser
What recovery options are there for NovaBay Pharmaceuticals Inc.2025 Technical Overview & Advanced Technical Analysis Signals - Newser
Using AI based signals to follow NovaBay Pharmaceuticals Inc.Exit Point & Intraday High Probability Setup Alerts - Newser
Automated trading signals detected on NovaBay Pharmaceuticals Inc.Chart Signals & Reliable Entry Point Alerts - Newser
What data driven models say about NovaBay Pharmaceuticals Inc.’s futureRecession Risk & Precise Buy Zone Tips - Newser
How to use a screener to detect NovaBay Pharmaceuticals Inc. breakoutsInsider Buying & Weekly Market Pulse Alerts - Newser
Using economic indicators to assess NovaBay Pharmaceuticals Inc. potentialJuly 2025 Momentum & Reliable Intraday Trade Plans - Newser
Long term hold vs stop loss in NovaBay Pharmaceuticals Inc.July 2025 Sector Moves & Growth Focused Entry Reports - Newser
Intraday pattern recognizer results for NovaBay Pharmaceuticals Inc.July 2025 Weekly Recap & Expert Curated Trade Ideas - Newser
Published on: 2025-09-08 01:50:48 - Newser
Will NovaBay Pharmaceuticals Inc. stock recover after recent dropJuly 2025 Opening Moves & Safe Entry Point Alerts - Newser
Is NovaBay Pharmaceuticals Inc. stock reversal real or fakeJuly 2025 Final Week & Capital Protection Trading Alerts - Newser
NovaBay Pharmaceuticals Stock Surges Amid Financial Resilience - timothysykes.com
How moving averages guide NovaBay Pharmaceuticals Inc. tradingMarket Performance Summary & Accurate Intraday Trading Signals - Newser
Can NovaBay Pharmaceuticals Inc. hit a new high this monthJuly 2025 News Drivers & Low Drawdown Momentum Trade Ideas - Newser
Is NovaBay Pharmaceuticals Inc. still worth holding after the dipWeekly Investment Report & AI Optimized Trade Strategies - Newser
Predicting NovaBay Pharmaceuticals Inc. trend using moving averages2025 Big Picture & Advanced Swing Trade Entry Plans - Newser
NovaBay Pharmaceuticals Faces Growth Challenges Amidst Financial Instabilities - StocksToTrade
Can NovaBay Pharmaceuticals Inc. maintain its current growth rateMarket Volume Summary & Technical Entry and Exit Tips - خودرو بانک
Is NovaBay Pharmaceuticals Inc. a play on infrastructure spendingWeekly Risk Report & Smart Swing Trading Alerts - خودرو بانک
Tick level data insight on NovaBay Pharmaceuticals Inc. volatilityJuly 2025 Analyst Calls & Daily Stock Trend Watchlist - Newser
What’s the MACD signal for NovaBay Pharmaceuticals Inc.2025 Retail Activity & Risk Managed Investment Entry Signals - خودرو بانک
Chart based exit strategy for NovaBay Pharmaceuticals Inc.Quarterly Trade Summary & Free Safe Entry Trade Signal Reports - Newser
What is NovaBay Pharmaceuticals Inc. s revenue forecast2025 Trading Recap & Reliable Price Breakout Signals - خودرو بانک
What to do if you’re stuck in NovaBay Pharmaceuticals Inc.July 2025 Update & Safe Entry Point Alerts - Newser
Is NovaBay Pharmaceuticals Inc. a candidate for recovery playEarnings Growth Summary & Daily Entry Point Trade Alerts - Newser
Novabay Pharmaceuticals Soars 17.54% on CEO Appointment, Dividend - AInvest
What’s the recovery path for long term holders of NovaBay Pharmaceuticals Inc.Earnings Growth Summary & Daily Entry Point Trade Alerts - Newser
Is NovaBay Pharmaceuticals Inc. stock entering bullish territory2025 Trade Ideas & Stepwise Trade Signal Implementation - Newser
What are the future prospects of NovaBay Pharmaceuticals Inc.2025 Winners & Losers & Risk Adjusted Swing Trade Ideas - خودرو بانک
Momentum Shift: What are NovaBay Pharmaceuticals Inc.’s recent SEC filings showingJuly 2025 Drop Watch & Technical Buy Zone Confirmation - خودرو بانک
Novabay Pharmaceuticals (NBY) Soars 17.54% on Strategic Moves, Five-Day 198.14% Rally - AInvest
Breakouts Watch: What hedge funds are buying NovaBay Pharmaceuticals Inc.2025 Price Targets & Daily Entry Point Alerts - خودرو بانک
NovaBay Pharma Appoints New CEO Amid Strategic Shift - MSN
NovaBay Pharmaceuticals Inc. stock chart pattern explainedEarnings Miss & AI Forecast Swing Trade Picks - Newser
What are NovaBay Pharmaceuticals Inc.’s earnings expectationsTrade Signal Summary & Fast Gain Stock Tips - خودرو بانک
Why Did Novabay Stock Soar 19.3%? - AInvest
How to build a custom watchlist for NovaBay Pharmaceuticals Inc.2025 Top Decliners & AI Based Buy and Sell Signals - Newser
Real time alert setup for NovaBay Pharmaceuticals Inc. performance2025 Market Sentiment & Stepwise Entry and Exit Trade Signals - Newser
Advanced analytics toolkit walkthrough for NovaBay Pharmaceuticals Inc.2025 Support & Resistance & Free Technical Pattern Based Buy Signals - Newser
Forecasting NovaBay Pharmaceuticals Inc. price range with options dataJuly 2025 Selloffs & Short-Term High Return Strategies - Newser
Tools to monitor NovaBay Pharmaceuticals Inc. recovery probabilityDividend Hike & Safe Capital Growth Tips - Newser
Is NovaBay Pharmaceuticals Inc. a turnaround story2025 Momentum Check & Free High Return Stock Watch Alerts - خودرو بانک
How to recover losses in NovaBay Pharmaceuticals Inc. stockMarket Trend Review & Community Shared Stock Ideas - Newser
Novabay Pharmaceuticals Inc Stock (NBY) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):